CymaBay Therapeutics Inc.

NASDAQ: CBAY · Real-Time Price · USD
32.48
0.01 (0.03%)
At close: Mar 21, 2024, 9:00 PM

CymaBay Therapeutics Ratios and Metrics

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
PE Ratio
-23.81 -4.63 -2.59
PEG Ratio
0.89 -1.2 -0.03
PS Ratio
80.73 n/a n/a
PB Ratio
8.58 15.23 1.81
P/FCF Ratio
-34.37 -6.54 -3.45
P/OCF Ratio
-34.59 -6.55 -3.46
OCF/S Ratio
-2.33 n/a n/a
Debt / Equity Ratio
0.39 2.51 0.39
Quick Ratio
10.96 8.94 10.41
Current Ratio
10.96 8.94 10.41
Asset Turnover
0.07 n/a n/a
Interest Coverage
-5.37 -6.25 -33.91
Return on Equity
-0.36 -3.29 -0.7
Return on Assets
-0.24 -0.84 -0.46
Return on Invested Capital
-0.25 -0.82 -0.49
Dividend Yield
n/a n/a n/a
Payout Ratio
n/a n/a n/a
Gross Profit Margin
0.98 n/a n/a
Net Profit Margin
-3.39 n/a n/a
Pretax Profit Margin
-3.39 n/a n/a
Operating Profit Margin
-3.27 n/a n/a
FCF Margin
n/a n/a n/a
EBITDA Margin
-2.76 n/a n/a